BioCryst Completes Acquisition of Astria Therapeutics, Strengthening Leadership in Hereditary Angioedema

BioCryst Pharmaceuticals, Inc.  announced that it has completed its acquisition of Astria Therapeutics, Inc., initially announced on October 14, 202...

January 26, 2026 | Monday | News
Affidea Acquires Majority Stake in LabPoint to Build Integrated Precision Diagnostics Platform in Switzerland

Affidea Group, Europe’s leading provider of advanced diagnostics, community-based polyclinics and specialised healthcare services including oncolog...

January 16, 2026 | Friday | News
Charles River to Acquire K.F. Cambodia and PathoQuest, Strengthening DSA Supply Chain and Expanding NAMs Capabilities

Signs Agreement to Acquire K.F. (Cambodia) Ltd. to Further Strengthen DSA Supply Chain; Transaction Expected to be Accretive to Non-GAAP Earnin...

January 13, 2026 | Tuesday | News
Lilly Bets on Chronic Inflammation With $1.2B All-Cash Acquisition of Ventyx

Eli Lilly and Company (NYSE: LLY) and Ventyx Biosciences, Inc. (Nasdaq: VTYX), a San Diego-based clinical-stage biopharmaceutical company focused on...

January 11, 2026 | Sunday | News
Amgen Acquires Dark Blue Therapeutics To Advance DBT 3757 For Acute Leukemia

  Lead candidate in the MLLT1/3 programme, DBT 3757, is a differentiated investigational molecule designed to treat Acute Myelo...

January 08, 2026 | Thursday | News
Fagron Completes Acquisition of Purifarma in Brazil

Fagron, the leading global player in pharmaceutical compounding, is pleased to announce the completion of Purifarma in Brazil, an important milestone in ...

January 07, 2026 | Wednesday | News
Earendil Labs and Sanofi Forge Strategic Collaboration to Advance AI-Discovered Bispecific Therapies for Autoimmune Diseases

Earendil Labs, a global leader in AI-driven research and development of next-generation biologics therapeutics, announced a strategic collaboration with ...

January 06, 2026 | Tuesday | News
Nutriband Sells 90% of Pocono Pharmaceutical to EarthVision Bio for $5M

Earthvision Bio, is currently developing and commercializing its line of sustainable products developed by Dr. Gordon Moore, the founder of Intel, and Dr. ...

December 31, 2025 | Wednesday | News
Sanofi to Acquire Dynavax for $2.2 Billion, Strengthening Adult Vaccines Portfolio

Dynavax stockholders to receive $15.50 in cash, a 39% premium to Dynavax closing share price onDecember 23, 2025 Sanofi announced that it has entered in...

December 25, 2025 | Thursday | News
Sobi Acquires Arthrosi for Up to USD 1.5 Billion, Securing Phase 3 Pozdeutinurad for Progressive Gout

Expands Sobi's pipeline with a highly differentiated new Phase 3 asset in Gout Acquisition expected to be highly accretive to...

December 15, 2025 | Monday | News
Viatris Secures $815 Million in Strategic Exit From Biocon Biologics Stake

Viatris to Receive $400 Million in Cash and $415 Million in Equity Shares of Biocon Limited Transaction Accelerates the Expiration of Biosimilars Non-Co...

December 08, 2025 | Monday | News
Johnson & Johnson to Acquire Halda in $3.05 Billion Deal to Expand First-in-Class RIPTAC™ Therapeutic Platform

Halda to be acquired by Johnson & Johnson for $3.05 billion in cash Halda recently presented positive Phase 1/2 data for HLD-0915 in metastatic ca...

November 18, 2025 | Tuesday | News
Repare Therapeutics Enters Definitive Agreement to Be Acquired by Xeno Therapeutics

Each shareholder is estimated to receive US$1.82 per share plus one CVR per common share - - Transaction expected to close in the first quarter of 20...

November 17, 2025 | Monday | News
Veloxity Labs and SCIEX Partner as First US Bioanalytical CRO to Bring ZenoTOF 8600 System Online

The first bioanalytical CRO in the United States to bring the ZenoTOF 8600 system online; expands capacity and adds selectivity/sensitivity headroom for GL...

November 05, 2025 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close